Use of 7- (2-oxa-5,8-diazabicyclo 4.3.0 non-8-yl -quinolonacarb oxy and -naphthylridonecarboxylic acid derivatives for the therapy of heliocobacter pylori infections and the gastroduodenal disorders associated with them

摘要

Invention Patent: B "USE OF ACID DERIVATIVES 7- (2-OXA-5,8-DIAZABICYCLE [4.3.0] NON-8-IL] -QUINOLONACARB OXYLIC AND -NAFTYL-RIDONACARBOXYLIC FOR THE THERAPY OF INFECTIONS OF INFECTIONS HELIOCOBACTER PYLORI AND GASTRODUODENAL DISORDERS ASSOCIATED WITH THE SAME "D. The invention relates to the use of quinolone- and naphthyhydronecarboxylic acid derivatives, which are replaced in position 7 by a radical of 2-oxa-5,8-diazabicycles [4.3.0] -non-8-ila), and their pharmaceutically usable salts and / or hydrates for the therapy of H. pylori infections and the gastroduodenal disorders associated with them.